Incidence and risk of cardiac toxicities in patients with relapsed and refractory multiple myeloma treated with carfilzomib

Incidence and risk of cardiac toxicities in patients with relapsed and refractory multiple myeloma treated with carfilzomib

Fang Zhao,1 Bo Yang,2 Juan Wang,1 Rui Zhang,1 Jing Liu,1 Fenglei Yin,1 Weixing Xu,1 Chunyuan He1 1Department of Hematology, Cangzhou Central Hospital, Cangzhou, People’s Republic of China; 2Department of Thoracic Surgery, Cangzhou Central Hospital, Cangzhou, People’s Republic of...

Full description

Bibliographic Details
Main Authors: Zhao F, Yang B, Wang J, Zhang R, Liu J, Yin F, Xu W, He C
Format: Article
Language:English
Published: Dove Medical Press 2018-05-01
Series:Drug Design, Development and Therapy
Subjects:
carfilzomib
cardiac toxicities
clinical trials
meta-analysis;
Online Access:https://www.dovepress.com/incidence-and-risk-of-cardiac-toxicities-in-patients-with-relapsed-and-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/incidence-and-risk-of-cardiac-toxicities-in-patients-with-relapsed-and-peer-reviewed-article-DDDT

Similar Items